Inhibitory effects of alpha-cyclodextrin and its derivative against sucrose-induced hyperglycemia in an in vivo evaluation system

Drug Discov Ther. 2018;12(3):122-125. doi: 10.5582/ddt.2018.01028.

Abstract

Cyclodextrins (CyDs) are cyclic oligosaccharides consisting of six to eight glucose residues. Administration of α-CyD (six glucose residues) inhibits sucrose-induced hyperglycemia in humans. Here we show that oral administration of α-CyD and dimethyl α-CyD suppresses sucrose-induced hyperglycemia in an in vivo evaluation system using silkworms. On the other hand, β-CyD (seven glucose residues), γ-CyD (eight glucose residues), and their derivatives did not show the suppressive effect. These findings suggest that dimethyl α-CyD is a new inhibitor against sucrose-induced hyperglycemia and the silkworm system is useful for evaluation of suppressive activities of α-CyD derivatives against postprandial hyperglycemia.

Keywords: Cyclodextrin; hyperglycemic activity; silkworm; sucrose-induced hyperglycemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • Bombyx
  • Hemolymph / chemistry
  • Hyperglycemia / chemically induced
  • Hyperglycemia / metabolism*
  • Sucrose / adverse effects
  • Sweetening Agents / adverse effects
  • alpha-Cyclodextrins / pharmacology*

Substances

  • Blood Glucose
  • Sweetening Agents
  • alpha-Cyclodextrins
  • dimethyl-alpha-cyclodextrin
  • Sucrose
  • alpha-cyclodextrin